The Journal of the American Dental Association
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Dent Assoc, Vol 134, No suppl_1, 16S-23S.
© 2003 American Dental Association

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ROBERTSON, C.
Right arrow Articles by VERNILLO, A. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ROBERTSON, C.
Right arrow Articles by VERNILLO, A. T.

ARTICLES

JADA Continuing Education

Update on diabetes diagnosis and management



CAROLYN ROBERTSON, A.P.R.N., M.S.N., C.D.E., B.C.-A.D.M., ANDREW JAY DREXLER, M.D. and ANTHONY T. VERNILLO, D.D.S., Ph.D.

Background. The American Diabetes Association has established recommendations for the testing of undiagnosed people. Once diagnosed, those with diabetes must strive to maintain a level of glucose control that results in a metabolism that approaches that of people without diabetes. The dentist also can provide risk-reduction strategies for people prone to develop diabetes, and refer patients with signs and symptoms suggestive of diabetes to physicians.

Methods. The authors describe criteria for establishing a diagnosis of diabetes and for identifying people at high risk of developing the disease. A combination of approaches in the medical management of type 1 and type 2 diabetes mellitus is presented, along with target outcomes.

Results. Patients with diabetes maintain a glycosylated hemoglobin value of no higher than 7 percent. New therapeutic research includes early clinical trials of islet cell transplantation and therapeutic cloning from human stem cells, which may provide an alternate source of insulin-producing islet cells and, thus, may offer a potential cure for diabetes.

Conclusions. Rigorous metabolic control of diabetes can be achieved through a combination of therapeutic modalities and the establishment and maintenance of target outcomes. The dentist can implement preventive strategies and refer patients with signs and symptoms suggestive of diabetes to physicians.

Clinical Implications. The dentist and physician must work together as a team to achieve rigorous metabolic control of diabetes in their patients.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. Vives-Bauza, M. Anand, A. K. Shirazi, J. Magrane, J. Gao, H. R. Vollmer-Snarr, G. Manfredi, and S. C. Finnemann
The Age Lipid A2E and Mitochondrial Dysfunction Synergistically Impair Phagocytosis by Retinal Pigment Epithelial Cells
J. Biol. Chem., September 5, 2008; 283(36): 24770 - 24780.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright©1995-2003 American Dental Association (ADA).
Reproduction or republication strictly prohibited without prior written permission of ADA.